○Yoshihide Sunada1, Shunichi Shirakawa1, Shin-ichiro Nishimatsu2, Yutaka Ohsawa1 (1.Neurology, Kawasaki Medical School, Japan, 2.Natural Science, Kawasaki Medical School)
Session information
Oral Session
[O-08] Oral Session 08
Wed. May 18, 2022 3:35 PM - 5:05 PM Room12 (Tokyo International Forum G Block 4F G402)
Chair:Yoshi Sunada(Department of Neurology, Kawasaki Medical School), Kazuma Sugie(Department of Neurology, Nara Medical University)
○Juri Hasegawa1, Tetsuya Nagata1, Kensuke Ihara2, Jun Tanihata3, Takanori Yokota1 (1.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 2.Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 3.Department of Cell Physiology, Division of Aerospace Medicine, Jikei University School of Medicine)
○Azusa Nagai1, Hiroaki Yaguchi1, Daiki Tanaka1, Yoichiro Fujioka2, Yusuke Oba2, Masashi Watanabe3, Takeshi Kondo3, Shigetsugu Hatakeyama3, Ichizo Nishino4, Ichiro Yabe1 (1.Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan, 2.Department of Cell Physiology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 3.Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 4.Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
○Daigo Miyazaki1,2, Mitsuto Sato1,5, Naoko Shiba3, Takahiro Yoshizawa4, Akinori Nakamura1,6 (1.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan, 2.Intractable Disease Care Center, Shinshu University Hospital, Japan, 3.Institute for Biomedical Sciences, Shinshu University, 4.Research Center for Supports to Advanced Science, Shinshu University, 5.Department of Brain Disease Research, Shinshu University School of Medicine, 6.Department of Clinical Research, National Hospital Organization Matsumoto Medical Center)
○Katsuhiko Kunitake1, Kazuki Okoshi1, Chaitra Sathyaprakash1, Norio Motohashi1, Yutaka Suzuki2, Yoshitsugu Aoki1 (1.Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan, 2.Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Japan)
○Nobuyuki Eura1,2, Masashi Ogasawara1, Shinichiro Hayashi1, Satoru Noguchi1, Ichizo Nishino1 (1.Department of Neuromuscular Research, National Center of Neurology and Psychiatry, Japan, 2.Department of Neurology, Nara Medical University, Nara, Japan)